These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20226273)

  • 1. To the editor--Market withdrawal of quinidine bisulfate (Kinidin Durules) in 2006.
    Olsson G
    Heart Rhythm; 2010 Jun; 7(6):864. PubMed ID: 20226273
    [No Abstract]   [Full Text] [Related]  

  • 2. To the editor--Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine.
    Viskin S; Belhassen B; Wilde AA
    Heart Rhythm; 2010 Jun; 7(6):863. PubMed ID: 20226268
    [No Abstract]   [Full Text] [Related]  

  • 3. To the editor:--Old drugs never die; they just fade away.
    Vardas PE; Kanoupakis EM
    Heart Rhythm; 2010 Jun; 7(6):864. PubMed ID: 20226270
    [No Abstract]   [Full Text] [Related]  

  • 4. To the editor: response---Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine.
    Estes NA; Page RL
    Heart Rhythm; 2010 Jun; 7(6):863-4. PubMed ID: 20226275
    [No Abstract]   [Full Text] [Related]  

  • 5. Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries.
    Viskin S; Wilde AA; Guevara-Valdivia ME; Daoulah A; Krahn AD; Zipes DP; Halkin A; Shivkumar K; Boyle NG; Adler A; Belhassen B; Schapachnik E; Asrar F; Rosso R
    J Am Coll Cardiol; 2013 Jun; 61(23):2383-7. PubMed ID: 23583244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry.
    Viskin S; Wilde AA; Tan HL; Antzelevitch C; Shimizu W; Belhassen B
    Heart Rhythm; 2009 Mar; 6(3):401-4. PubMed ID: 19251219
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine.
    Schweizer PA; Becker R; Katus HA; Thomas D
    Clin Res Cardiol; 2010 Jul; 99(7):467-70. PubMed ID: 20221832
    [No Abstract]   [Full Text] [Related]  

  • 8. Quinidine: a valuable medication joins the list of 'endangered species'.
    Viskin S; Antzelevitch C; Márquez MF; Belhassen B
    Europace; 2007 Dec; 9(12):1105-6. PubMed ID: 17761793
    [No Abstract]   [Full Text] [Related]  

  • 9. One small step.
    Link M; Kowey P
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):291-3. PubMed ID: 19272056
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse effects of long-term therapeutic doses of quinidine in asymptomatic Brugada patients: should low doses be used first?
    Márquez MF; Tonet J
    Europace; 2014 Jul; 16(7):1100. PubMed ID: 24459248
    [No Abstract]   [Full Text] [Related]  

  • 11. Side effects could certainly be decreased with lower dose of quinidine in asymptomatic Brugada patients, but what about efficacy? Author reply.
    Bouzeman A; Leenhardt A
    Europace; 2014 Jul; 16(7):1100-1. PubMed ID: 24459247
    [No Abstract]   [Full Text] [Related]  

  • 12. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinidine in Brugada Syndrome: Still a Long Way to Go….
    Probst V; Gourraud JB
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1309-10. PubMed ID: 26671933
    [No Abstract]   [Full Text] [Related]  

  • 14. High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome.
    Sumi S; Maruyama S; Shiga Y; Kodama S; Miyoshi K; Tojou H; Yamanouchi Y; Urata H
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):e53-6. PubMed ID: 20059716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Orphan drugs' in cardiology: nadolol and quinidine.
    Inama G; Durin O; Pedrinazzi C; Berisso MZ; Furlanello F
    J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):143-4. PubMed ID: 19829129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.
    Kyriazis K; Bahlmann E; van der Schalk H; Kuck KH
    Europace; 2009 May; 11(5):665-6. PubMed ID: 19346290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of quinidine in high-risk patients with Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On Brugada syndrome.
    Zeller L; Shalev A
    Isr Med Assoc J; 2008 Oct; 10(10):743; author reply 743. PubMed ID: 19009962
    [No Abstract]   [Full Text] [Related]  

  • 19. Quinidine therapy in children affected by Brugada syndrome: are we far from a safe alternative?
    Baruteau AE; Mabo P; Probst V
    Cardiol Young; 2009 Dec; 19(6):652-4. PubMed ID: 19737438
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
    Bouzeman A; Traulle S; Messali A; Extramiana F; Denjoy I; Narayanan K; Marijon E; Hermida JS; Leenhardt A
    Europace; 2014 Apr; 16(4):572-7. PubMed ID: 24068450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.